Merck’s Keytruda prolonged recurrence-free survival in late-stage melanoma study
05 August 2021 - 10:32PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Merck (NYSE:MRK)
Historical Stock Chart
From Apr 2024 to May 2024
Merck (NYSE:MRK)
Historical Stock Chart
From May 2023 to May 2024